EKF Diagnostics Holdings (LSE:EKF) ROCE %: 9.54% (As of Dec. 2025)


LSE:EKF EKF Diagnostics Holdings PLC LSE:EKF
54 GF Score
Price £0.27
GF Value £0.28
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is EKF Diagnostics Holdings ROCE %?

EKF Diagnostics Holdings LSE:EKF +0.75% 54 ROCE % is 9.54% as of Dec. 2025. GuruFocus rates LSE:EKF with a GF Score™ of 54/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. EKF Diagnostics Holdings's annualized ROCE % for the quarter that ended in Dec. 2025 was 9.54%.

EKF Diagnostics Holdings  (LSE:EKF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

EKF Diagnostics Holdings ROCE % Related Terms

EKF Diagnostics Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for EKF Diagnostics Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EKF Diagnostics Holdings ROCE % Chart

EKF Diagnostics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.46 -9.88 2.96 8.77 9.72

EKF Diagnostics Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.37 8.72 8.75 9.75 9.54
LSE:EKF
54GF Score
EKF Diagnostics Holdings PLC LSE:EKF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EKF Diagnostics Holdings ROCE % Calculation

EKF Diagnostics Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=7.24/( ( (81.745 - 6.437) + (81.137 - 7.42) )/ 2 )
=7.24/( (75.308+73.717)/ 2 )
=7.24/74.5125
=9.72 %

EKF Diagnostics Holdings's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=7.124/( ( (82.43 - 6.823) + (81.137 - 7.42) )/ 2 )
=7.124/( ( 75.607 + 73.717 )/ 2 )
=7.124/74.662
=9.54 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.54% mean?
EKF Diagnostics Holdings (LSE:EKF) has a ROCE % of 9.54% as of Dec. 2025.
Is EKF Diagnostics Holdings' ROCE % too high?
EKF Diagnostics Holdings' current ROCE % is 9.54%. The Medical Devices & Instruments industry median ROCE % is 2.23. EKF Diagnostics Holdings' value of 9.54% is 327.8% above this industry median. Overall, EKF Diagnostics Holdings has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' ROCE % compare to ABT and SYK?
EKF Diagnostics Holdings' ROCE % of 9.54% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. EKF Diagnostics Holdings' value of 9.54% is 327.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EKF Diagnostics Holdings's current ROCE % of 9.54% is 327.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current ROCE % is 9.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.27 — trading 3.6% below its estimated fair value. The current ROCE % is 9.54% and 327.8% above the Medical Devices & Instruments industry median of 2.23. EKF Diagnostics Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current ROCE % is 9.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?

Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued. The current stock price of £0.27 is trading 3.6% below its estimated GF Value™ of £0.28. GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.

Key valuation signals for LSE:EKF:

  • ROCE %: 9.54%
  • GF Value™: £0.28 vs. price of £0.27 (3.6% below fair value)
  • GF Score™: 54/100 with 4 warning signs
  • Industry Position: 327.8% above the Medical Devices & Instruments median

No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EKF Diagnostics Holdings Business Description

Other Exchanges EKDHF:USALYF:Germany
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
54GF Score

Get the complete analysis for LSE:EKF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.27
Price
£0.28
GF Value